Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114724 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections
A NA study of Aortic Dissection, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 17
- Study locations
NCT01114724 is a NA study of Aortic Dissection that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 50 participants, below the 660-participant average among 11 other Aortic Dissection trials with a reported enrollment target (92% lower). The trial reports 17 study locations across 11 states.
The verdict
NCT01114724, a NA study of Aortic Dissection, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 17
- Study locations
Study Summary
The purpose of this study is to determine if the Valiant stent graft is safe and effective in treating patients who have a thoracic dissection. A thoracic dissection is a tear in the wall of the aorta, that causes blood to flow between the layers of the aorta and force the layers apart (dissect). This condition is a medical emergency and can quickly lead to death. Since stent grafting has been an effective way to treat other aortic conditions such as aneurysms (bulge in aorta wall), it is believed that the device would be effective in treating dissections. Information will be collected on the performance of the device for 5 years.
Conditions Studied
Interventions
- DEVICE Valiant Thoracic Stent Graft with the Captivia Delivery System
Study Locations (17)
Texas
- Heart Hospital Medical Center - Dallas
- Baylor - Houston
- Memorial Hermann Heart and Vascular Institute - Houston
- St. Luke's Episcopal Hospital - Houston
California
- USC Keck School of Medicine - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Harbor UCLA - Torrance
North Carolina
- Novant Health Heart and Vascular Institute - Charlotte
- Duke University Medical Center - Durham
District of Columbia
- Washington Hospital D.C. - Washington D.C.
Florida
- University of Florida - Gainesville
Illinois
- Northwestern Memorial - Chicago
Michigan
- University of Michigan - Ann Arbor
New York
- New York Presbyterian Weill Cornell - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-05 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114724
The ClinicalTrials.gov registry entry for NCT01114724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 660-participant average among 11 other Aortic Dissection trials with a reported enrollment target (92% lower). The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Dissection appearing as the primary indexed condition, and to 1 intervention - of which Valiant Thoracic Stent Graft with the Captivia Delivery System is the first listed.
NCT01114724 reports 17 study locations spanning 11 distinct geographic areas - top geographies include Texas, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01114724 about?
NCT01114724 is a clinical study titled "Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections". The purpose of this study is to determine if the Valiant stent graft is safe and effective in treating patients who have a thoracic dissection. A thoracic dissection is a tear in the wall of the aorta, that causes blood to flow between the layers of the aorta and force the layers apart (dissect). Th...
What is the current status of trial NCT01114724?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-05. Estimated completion is 2017-10.
What conditions does trial NCT01114724 study?
This clinical trial studies the following conditions: Aortic Dissection.
What interventions are being tested in trial NCT01114724?
The interventions under investigation include: Valiant Thoracic Stent Graft with the Captivia Delivery System (DEVICE).
Who is sponsoring clinical trial NCT01114724?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01114724 being conducted?
This trial has 17 study locations across California, District of Columbia, Florida, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Dissection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
RECRUITING · NA
-
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
RECRUITING · NA
-
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.